EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lower Degree of Microsatellite Instability in Colorectal Carcinomas From MSH6-Associated Lynch Syndrome Patients

Noah C Helderman, Fabian Strobel, Lena Bohaumilitzky, Diantha Terlouw, Anne-Sophie van der Werf-'t Lam, Tom van Wezel, Hans Morreau, Magnus von Knebel Doeberitz, Maartje Nielsen, Matthias Kloor, Aysel Ahadova

Modern Pathology · 2025-07 · 38 (7) · 100757

DOI: 10.1016/j.modpat.2025.100757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025-07. Verfasst von Noah C Helderman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Microsatellite Instability, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA-Binding Proteins, Colorectal Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: René Vogels Foundation, Digestive Diseases Foundation, Wilhelm Sander Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous observational and molecular studies focusing on Lynch syndrome (LS) have revealed significant variation in the phenotype and molecular characteristics among carriers of pathogenic variants in mismatch repair genes (path_MMR). Recently, we demonstrated that colorectal carcinomas in path_MSH6 carriers exhibit fewer insertion/deletion mutations compared with cumulative colorectal cancers (CRCs) from other MMR groups, raising the question of whether MSH6-mutated CRCs might display a relatively lower degree of microsatellite instability (MSI). Mutations at 20 coding microsatellites (cMS) were analyzed in 39 MSH6-, 18 MLH1-, 16 MSH2-, and 22 PMS2-mutated CRCs and 35 sporadic MSI CRCs, and mutation frequencies and mutant allele ratios were compared among the different MMR-deficient groups. Considering factors such as HLA-A∗02:01 type, B2M status, and the anticipated immunogenicity of frameshift peptides derived from cMS mutations, the identified cMS mutation profiles of MSH6-mutated CRCs were further investigated to assess their potential impact on immunotherapeutic strategies. MSH6-mutated CRCs exhibited lower mutation frequencies and mutant allele ratios across most cMS. Variation in cMS mutation patterns was observed both between different tumor regions and between tumor tissue and adjacent adenomatous tissue. The cMS mutations in MSH6-mutated CRCs demonstrated inverse correlations with the predicted immunogenicity of the resulting frameshift peptides, which may suggest a negative selection of cell clones bearing highly immunogenic frameshift peptides. Overall, MSH6-mutated CRCs display a relatively lower degree of MSI and represent a biologically distinct subgroup of LS-associated CRCs. This lower MSI level may implicate an altered immune response compared with other MSI CRCs, which could have theoretical implications for the success of immunotherapy in MSH6-mutated CRCs. Future studies should carefully evaluate this possibility. If confirmed, these results would reinforce the notion of classifying LS as distinct syndromes associated with specific MMR genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Microsatellite InstabilityColorectal Neoplasms, Hereditary NonpolyposisDNA-Binding ProteinsColorectal NeoplasmsHumansFemaleMaleMiddle AgedAdultAgedMutation

Stichwörter der Autor:innen

coding microsatellitescolorectal cancerframeshift peptideslynch syndromemicrosatellite instabilitymismatch repair

Substanzen

G-T mismatch-binding proteinDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Applied Tumor Biology, Heidelberg University Hospital, Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany. Electronic address: Aysel.Ahadova@med.uni-…

Förderung

  • René Vogels Foundation
  • Digestive Diseases Foundation
  • Wilhelm Sander Foundation
  • Klaus Tschira Foundation

Zitieren

APA

Helderman, N. C., Strobel, F., Bohaumilitzky, L., Terlouw, D., van der Werf-'t Lam, A. S., van Wezel, T., Morreau, H., von Knebel Doeberitz, M., Nielsen, M., Kloor, M., & Ahadova, A. (2025). Lower Degree of Microsatellite Instability in Colorectal Carcinomas From MSH6-Associated Lynch Syndrome Patients. Modern Pathology, 38(7), 100757. https://doi.org/10.1016/j.modpat.2025.100757

Vancouver

Helderman NC, Strobel F, Bohaumilitzky L, Terlouw D, van der Werf-'t Lam AS, van Wezel T, et al. Lower Degree of Microsatellite Instability in Colorectal Carcinomas From MSH6-Associated Lynch Syndrome Patients. Modern Pathology. 2025;38(7):100757. doi:10.1016/j.modpat.2025.100757

BibTeX
@article{Helderman2025,
  author = {Helderman, Noah C and Strobel, Fabian and Bohaumilitzky, Lena and Terlouw, Diantha and van der Werf-'t Lam, Anne-Sophie and van Wezel, Tom and Morreau, Hans and von Knebel Doeberitz, Magnus and Nielsen, Maartje and Kloor, Matthias and Ahadova, Aysel},
  title = {Lower Degree of Microsatellite Instability in Colorectal Carcinomas From MSH6-Associated Lynch Syndrome Patients},
  journal = {Modern Pathology},
  year = {2025},
  volume = {38},
  number = {7},
  pages = {100757},
  doi = {10.1016/j.modpat.2025.100757}
}
Kostenlos starten →